제노레이

122310KOSDAQ의료용 기기 제조업

55.9 / 100

Reference Date: 2026-04-13

Financial Score15.0 / 40

News Sentiment16.9 / 25

Momentum12.0 / 20

Disclosure12.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but PER raises overvaluation concerns. Slightly up 1.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Genoray develops, manufactures, and sells X-ray imaging diagnostic equipment for medical and dental environments. The company operates both medical (C-arm, Mammography) and dental (Panorama, CT, Portable) segments, uniquely being the only South Korean firm offering both. The medical segment focuses on real-time imaging during surgeries and breast disease diagnosis, while the dental segment provides high-resolution 3D imaging technology for dental treatments and implant surgery.

Number of Employees

358people

Average Salary

56.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

72.79Industry Average 26.520.0Point

2.7x industry avg (risky)

PBR

0.77Industry Average 1.707.0Point

Half of industry avg (excellent)

ROE

0.74Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

8.99Industry Average 10.954.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼76.4% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.8% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
제노레이, KIMES 2026에서 '보건복지부장관상' 수상
제노레이가 KIMES 2026에서 '보건복지부장관상'을 수상하고 C-arm 전 라인업의 CE MDR 인증 체계 구축 성과를 공개하며 글로벌 계약 기대감을 높였습니다.
Positive
제노레이, KIMES 2026서 C-Arm 제품군 공개…글로벌 판매 ...
제노레이가 KIMES 2026에서 C-Arm 제품군을 공개하며 국내외 시장에서 기술 경쟁력과 사업 확대 가능성을 확인했습니다.
Positive
제노레이 박병욱 대표 측 지분 26.9%로 확대
제노레이 박병욱 대표이사 측 지분율이 장내 매수로 기존 26.88%에서 26.90%로 소폭 증가했습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (30%)

Current 4,440Won52-week high 5,91052-week low 3,810

1-month return3.0Point

1m 1.83% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

7 totalPositive 1Neutral 6Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-08
Positive현금ㆍ현물배당결정2026-04-01
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-30
Neutral정기주주총회결과2026-03-27
Neutral감사보고서제출2026-03-19